iShares U.S. Pharmaceuticals ETF (IHE)

NYSEArca

100.19
+0.10 (+0.10%)
Updated Oct 13, 5:01 AM ET
AI Rating
Hold
Overall Score
56
Trend
57
Momentum
41
Risk
74

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 30, 2025 260 sessions Oct 12, 2026

AI Analysis

iShares U.S. Pharmaceuticals ETF is trading at $100.19, up 0.10% on the session. The 50 day average sits at $102.64 and the 200 day at $93.49, which puts the stock in a uptrend. RSI is at 45.4, which reads as neutral, and MACD is bearish crossover. Volume is above average.

The nearest support is around $99.66 with resistance near $103.64, so that band frames the current range. Average daily movement is roughly $1.75, or about 1.7% of the share price, which is what any stop placement has to allow for. The overall health score of 56 out of 100 combines a trend score of 57, momentum of 41 and a risk score of 74.

Technical indicators

RSI (14)
45.4
neutral
MACD
-1.027
bearish crossover
SMA 20
100.88
SMA 50
102.64
SMA 200
93.49
uptrend
ATR (14)
1.75
avg daily range
Support
99.66
Resistance
103.64
Volume vs 20d
1.49x
above average
Volatility
15.1%
annualised
1 month
-1.17%
3 months
+0.10%

About iShares U.S. Pharmaceuticals ETF

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.